Production, titration, neutralisation, storage and lyophilisation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lentiviral pseudotypes

C Di Genova, A Sampson, S Scott, D Cantoni… - Bio …, 2021 - bio-protocol.org
This protocol details a rapid and reliable method for the production and titration of high-titre
viral pseudotype particles with the SARS-CoV-2 spike protein (and D614G or other variants …

Production, titration, neutralisation and storage of SARS-CoV-2 lentiviral pseudotypes

C Di Genova, A Sampson, S Scott, D Cantoni… - Bio-protocol, 2021 - gala.gre.ac.uk
This protocol details a rapid and reliable method for the production and titration of high-titer
viral pseudotype particles with the SARS-CoV-2 spike protein (and D614G variant) on a …

Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus

X Fu, L Tao, X Zhang - Molecular Therapy-Methods & Clinical Development, 2021 - cell.com
Virus neutralization assay is principally conducted by measuring the ability of the antibodies
in patient sera to prevent the infection of susceptible cells by the virus. As SARS-CoV-2 is …

Generation of SARS-CoV-2 spike pseudotyped virus for viral entry and neutralization assays: a 1-week protocol

JM Condor Capcha, G Lambert… - Frontiers in …, 2021 - frontiersin.org
The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus requires reliable assays
for studying viral entry mechanisms which remains poorly understood. This knowledge is …

A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein

S Roy, K Ghani, PO de Campos-Lima, M Caruso - Virus research, 2021 - Elsevier
In this study, we showed that a codon optimized version of the spike (S) protein of SARS-
CoV-2 can migrate to the cell membrane. However, efficient production of Moloney murine …

Functional assessments of SARS-CoV-2 single-round infectious particles with variant-specific spike proteins on infectivity, drug sensitivity, and antibody neutralization

WC Su, ZY Chen, YS Chang, KS Jeng, UNP Le… - Antiviral Research, 2023 - Elsevier
Working with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is restricted to
biosafety level III (BSL-3) laboratory. The study used a trans-complementation system …

Optimized pseudotyping conditions for the SARS-COV-2 spike glycoprotein

MC Johnson, TD Lyddon, R Suarez, B Salcedo… - Journal of …, 2020 - Am Soc Microbiol
The severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) Spike glycoprotein is
solely responsible for binding to the host cell receptor and facilitating fusion between the …

Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein

R Tandon, D Mitra, P Sharma, MG McCandless… - Scientific reports, 2020 - nature.com
Pseuodotyped particles have significant importance and use in virology as tools for studying
the biology of highly pathogenic viruses in a lower biosafety environment. The biological …

A simplified SARS-CoV-2 pseudovirus neutralization assay

G Donofrio, V Franceschi, F Macchi, L Russo, A Rocci… - Vaccines, 2021 - mdpi.com
COVID-19 is an ongoing pandemic caused by the highly infectious coronavirus SARS-CoV-
2 that is engaging worldwide scientific research to find a timely and effective eradication …

An optimized method for the production using PEI, titration and neutralization of SARS-CoV spike luciferase pseudotypes

G Carnell, K Grehan, F Ferrara, E Molesti… - Bio …, 2017 - bio-protocol.org
The protocol outlined represents a cost-effective, rapid and reliable method for the
generation of high-titre viral pseudotype particles with the wild-type SARS-CoV spike protein …